Loading....

Tag: Health

Formation of the ‘Veterinary Vaccine India Manufacturers Association’ – VVIMA

New Delhi [India], September 27: In a significant development for India’s animal health sector, veterinary vaccine manufacturers have come together to announce the formation of the Veterinary Vaccine India Manufacturers Association (VVIMA). VVIMA is a non-government, not-for-profit organization that will serve as the collective voice of India’s veterinary vaccine manufacturers. The association will actively collaborate […]

Egg Freezing Gains Popularity in India: Dr. S. Vyjayanthi on the Future of Fertility Preservation

Hyderabad (Telangana) [India], September 25:  Fertility preservation is no longer a subject confined to medical textbooks and oncology wards—it is now part of mainstream conversations among India’s urban, career-driven women. One procedure leading this change is egg freezing, and guiding this shift with expertise and compassion is Dr S. Vyjayanthi, Director of MotherToBe Fertility Centre and […]

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences

Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the synergy between two healthcare leaders committed to advanced cancer treatment accessibility. Innovation Meets […]

Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India

Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with Enzene Biosciences Limited, this breakthrough aims to reduce the economic barriers faced by thousands of HER2-positive breast cancer patients. […]

Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care

Hyderabad (Telangana) [India], September 25: Reinforcing the Government of India’s mission to provide equitable healthcare, Hetero Healthcare Limited, in partnership with Enzene Biosciences, has launched Perzea, its most affordable biosimilar Pertuzumab for HER2-positive breast cancer. This initiative underlines the critical need for advanced cancer treatment accessibility in the country. Closing the Treatment Gap Pertuzumab, a globally accepted monoclonal antibody therapy, […]

Top